Generate a tailored SOP for Dr. Hamideh Parhiz. Improve your application with a focused, well-structured draft.
Hamideh Parhiz holds a PharmD and a PhD, focusing on Pharmaceutical Biotechnology. She is an Assistant Professor in the Department of Systems Pharmacology and Translational Therapeutics at the Perelman School of Medicine, University of Pennsylvania. Her research expertise lies in nucleic acid-based therapeutics, nano-engineering, and targeted delivery nanomedicine. Parhiz's lab is dedicated to the development of novel nucleic acid delivery systems, including the next generation of targeted lipid nanoparticles (tLNPs). Her work emphasizes the applications of mRNA therapeutics across a variety of non-vaccine contexts, including inherited disorders, congenital hematopoietic conditions, cancers, fibrosis, and acute inflammatory conditions. In addition, she investigates the mechanisms underlying the enhancement of delivery systems, particularly those associated with favorable pharmacokinetic profiles. Parhiz's current projects revolve around designing effective gene mRNA therapeutics, establishing a targeted LNP-mRNA platform that is foundational for ongoing academic programs and industrial product developments.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.